|
0
|
|
Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy.
(linkinghub.elsevier.com)
|
Mallard de La Varende AL
…
Zitvogel L
Cancer Cell
2026-07-29
|
#dysbiosis
#immunotherapy
#bile acids
#microbiome
#immunoresistance
|
|
0
|
|
An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer.
(linkinghub.elsevier.com)
|
Gu Y
…
Guan X
Cell Reports Medicine
2026-07-29
|
#cancer
#immunotherapy
#protac
#protein degradation
#targeted delivery
|
|
0
|
|
Cancer is embedded in a whole-body neural regulatory network.
(science.org)
|
Sloan EK
Science Translational Medicine
2026-07-29
|
#cancer
#metastasis
#neuroimmunology
#microenvironment
#immunotherapy
|
|
0
|
|
A distinct CAR-T cell phenotype mediates therapeutic response at limited doses.
(nature.com)
|
Yousefian S
…
Haas S
Nature Communications
2026-07-29
|
#immunotherapy
#lymphoma
#t-cells
#biomarker
#phenotyping
|
|
0
|
|
Depletion of an immature cord blood NK subset reverses trogocytosis-driven CAR NK dysfunction.
(linkinghub.elsevier.com)
|
Li Y
…
Rezvani K
Cancer Cell
2026-07-29
|
#immunotherapy
#car-nk
#trogocytosis
#cell engineering
#exhaustion
|
|
0
|
|
Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma.
(linkinghub.elsevier.com)
|
Karapetyan L
…
Pilon-Thomas S
Cell Med
2026-07-29
|
#immunotherapy
#melanoma
#transcriptomics
#immunophenotyping
#checkpoint-inhibitors
|
|
0
|
|
Glioblastoma: Overcoming fundamental biological and delivery barriers to therapy.
(science.org)
|
Villa GR
…
Chiocca EA
Science Translational Medicine
2026-07-29
|
#glioblastoma
#immunotherapy
#drug delivery
#precision medicine
#tumor microenvironment
|
|
0
|
|
Targeting therapeutic nanoparticles to the glioblastoma resection margin by harnessing postoperative blood-brain barrier disruption.
(science.org)
|
Fernandes LF
…
Kisby T
Science Translational Medicine
2026-07-29
|
#nanoparticles
#glioblastoma
#drug delivery
#blood-brain barrier
#immunotherapy
|
|
0
|
|
Psoriasis.
(linkinghub.elsevier.com)
|
Eder L
…
Merola JF
The Lancet
2026-07-29
|
#psoriasis
#immunity
#inflammation
#immunotherapy
#cytokine
|
|
0
|
|
Robust CD4(+) CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.
(science.org)
|
Jurgens EM
…
Mailankody S
Science Translational Medicine
2026-07-29
|
#car-t
#immunotherapy
#toxicity
#myeloma
#neurotoxicity
|
|
0
|
|
Bile acids in cancer: From metabolism to immunomodulation.
(linkinghub.elsevier.com)
|
Fang Q
…
Schneider KM
Immunity
2026-07-29
|
#microbiome
#cancer
#immunotherapy
#metabolism
#immunometabolism
|
|
0
|
|
CRISPR screens identify targets to rescue age-related T cell dysfunction in cancer.
(linkinghub.elsevier.com)
|
Chen ACY
…
Sen DR
Cell
2026-07-29
|
#immunotherapy
#crispr
#immunosenescence
#cancer
#t-cells
|
|
0
|
|
Single-cell profiling of natural killer/T-cell lymphoma reveals stratified immune features and potential therapeutic implications.
(nature.com)
|
Cao Y
…
Cai Q
Nature Communications
2026-07-29
|
#transcriptomics
#lymphoma
#immunotherapy
#heterogeneity
#proteomics
|
|
0
|
|
Cancer neuroscience: Mechanisms to medicine.
(science.org)
|
Pasvolsky L
…
Amit M
Science Translational Medicine
2026-07-29
|
#neurobiology
#oncology
#immunity
#immunotherapy
#translational
|